Intercept Pharmaceuticals
ICPT
#6565
Rank
NZ$1.44 B
Marketcap
NZ$34.66
Share price
0.00%
Change (1 day)
-6.05%
Change (1 year)

Earnings for Intercept Pharmaceuticals (ICPT)

Earnings in 2023 (TTM): -NZ$92.64 Million

According to Intercept Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.31 Billion. In 2022 the company made an earning of -NZ$0.3 Billion a decrease over its 2021 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intercept Pharmaceuticals from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$92.64 Million-68.11%
2022 -NZ$0.3 Billion74.17%
2021 -NZ$0.17 Billion-66.74%
2020 -NZ$0.51 Billion-20.25%
2019 -NZ$0.63 Billion11.46%
2018 -NZ$0.57 Billion-14.19%
2017 -NZ$0.66 Billion-12.71%
2016 -NZ$0.76 Billion82.32%
2015 -NZ$0.42 Billion-23.21%
2014 -NZ$0.54 Billion334.95%
2013 -NZ$0.13 Billion60.48%
2012 -NZ$77.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$63.43 B-60,036.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$4.63 Billion 4,266.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.67 B-19,634.56%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.61 Million-81.47%๐Ÿ‡บ๐Ÿ‡ธ USA